Position in STE
as of Mar 31, 2026
· filed Apr 29, 2026
Position Value
$753,611
+$373,078 QoQ
Shares Held
3,408
+127.0% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in STE Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026Brooklyn Investment Group holds $29,787,869 across 29 Medical Devices names. STE ranks #11 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
66,749 | $6,853,119 | |
| 2 | BSX |
Boston Scientific Corp
|
53,712 | $3,370,428 | |
| 3 | SYK |
Stryker Corp
|
9,379 | $3,081,845 | |
| 4 | PEN |
Penumbra Inc
|
6,800 | $2,232,916 | |
| 5 | MDT |
Medtronic plc
|
19,747 | $1,711,077 | |
| 6 | PHG |
Koninklijke Philips NV
|
48,304 | $1,323,529 | |
| 7 | BVS |
Bioventus Inc.
|
116,219 | $1,061,079 | |
| 8 | PRCT |
PROCEPT BioRobotics Corp
|
42,388 | $1,060,123 |
All Filings in STE
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $753,611 | 3,408 | Shares | Defined | 2026-04-29 | |
| 2025-12-31 | $380,533 | 1,501 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $223,190 | 902 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $215,717 | 898 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $125,790 | 555 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $19,528 | 95 | Shares | Defined | 2025-01-15 | |
| 2024-09-30 | $18,433 | 76 | Shares | Defined | 2024-11-13 | |
| No filing history on record for this holder in this stock. | ||||||